Postmortem data support link between gene and schizophrenia

September 12, 2005

We have known for a long time that there is a genetic component to schizophrenia, but nailing down the gene(s) has not been easy. The disease is complex, with multiple genes and environmental factors thought to be responsible for its manifestation. Several genes have been linked to schizophrenia, and a new study on one of the candidates, by Linda Brzustowicz and colleagues (Rutgers University), just published in the international open-access journal PLoS Medicine, further implicates the CAPON gene.

The researchers had previously found a connection between CAPON and schizophrenia in families where the disease is common, and other groups had seen a similar connection in their samples. This was intriguing because CAPON is part of a molecular pathway that is active in the brain and which might play a role in diseases like schizophrenia. In the present study, Brzustowicz and colleagues examined postmortem brain samples for differences in CAPON gene activity between normal individuals and those with mental illness. And in their set of 35 samples each from individuals with schizophrenia, individuals with bipolar disorder, and individuals without mental illness, they found such differences.

Genes are templates for proteins (which make up the majority of active components in cells and body), and the researchers found that the CAPON gene is a template for two different proteins, a short form and a long form. The brain samples from patients with schizophrenia and bipolar disorder had higher levels of the short form than brain samples from patients without psychiatric illness. Moreover, these higher levels of the short version were predominantly seen in people with variants of the CAPON gene that had been previously linked to schizophrenia.

These results lend more support to the idea that CAPON is involved in schizophrenia. Given the cumulative evidence, it seems clear that further study of CAPON is justified. The findings by Brzustowicz and colleagues suggest that we need to learn more about the short version of CAPON, and specifically its presence and function in the brain.
Citation: Xu B, Wratten N, Charych EI, Buyske S, Firestein BL, et al. (2005) Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder. PLoS Med 2(10): e263.

Linda Brzustowicz
Rutgers University
604 Allison Road
Piscataway, NJ USA 07940
1-732-445-1636 (fax)

PLEASE MENTION PLoS Medicine ( AS THE SOURCE FOR THESE ARTICLES. THANK YOU. All works published in PLoS Medicine are open access. Everything is immediately available without cost to anyone, anywhere--to read, download, redistribute, include in databases, and otherwise use--subject only to the condition that the original authorship is properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License.


Related Schizophrenia Articles from Brightsurf:

Schizophrenia: When the thalamus misleads the ear
Scientists at the University of Geneva (UNIGE) and the Synapsy National Centre of Competence in Research (NCCR) have succeeded in linking the onset of auditory hallucinations - one of the most common symptoms of schizophrenia - with the abnormal development of certain substructures of a region deep in the brain called the thalamus.

Unlocking schizophrenia
New research, led by Prof. LIU Bing and Prof. JIANG Tianzi from the Institute of Automation of the Chinese Academy of Sciences and their collaborators have recently developed a novel imaging marker that may help in the personalized medicine of psychiatric disorders.

Researchers discover second type of schizophrenia
In a study of more than 300 patients from three continents, over one third had brains that looked similar to healthy people.

New clues into the genetic origins of schizophrenia
The first genetic analysis of schizophrenia in an ancestral African population, the South African Xhosa, appears in the Jan.

Dietary supplement may help with schizophrenia
A dietary supplement, sarcosine, may help with schizophrenia as part of a holistic approach complementing antipsychotic medication, according to a UCL researcher.

Schizophrenia: Adolescence is the game-changer
Schizophrenia may be related to the deletion syndrome. However, not everyone who has the syndrome necessarily develops psychotic symptoms.

Study suggests overdiagnosis of schizophrenia
In a small study of patients referred to the Johns Hopkins Early Psychosis Intervention Clinic (EPIC), Johns Hopkins Medicine researchers report that about half the people referred to the clinic with a schizophrenia diagnosis didn't actually have schizophrenia.

The ways of wisdom in schizophrenia
Researchers at UC San Diego School of Medicine report that persons with schizophrenia scored lower on a wisdom assessment than non-psychiatric comparison participants, but that there was considerable variability in levels of wisdom, and those with higher scores displayed fewer psychotic symptoms.

Recognizing the uniqueness of different individuals with schizophrenia
Individuals diagnosed with schizophrenia differ greatly from one another. Researchers from Radboud university medical center, along with colleagues from England and Norway, have demonstrated that very few identical brain differences are shared amongst different patients.

Resynchronizing neurons to erase schizophrenia
Today, a decisive step in understanding schizophrenia has been taken.

Read More: Schizophrenia News and Schizophrenia Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to